Amylyx Pharmaceuticals, Inc. (AMLX) /
The profitability of Amylyx Pharmaceuticals, Inc. over the past 5 years
Chart Amylyx Pharmaceuticals, Inc.: gross profit, operating income, net income, fiscal 2021–2025 Open the chart →Amylyx Pharmaceuticals, Inc. reported a net loss of $144.74M in fiscal 2025, the latest fiscal year on file. That year it had gross profit of $0 and an operating loss of $153.29M. It reported a profit in 1 of the 5 years shown, and a loss in fiscal 2021, 2022, 2024 and 2025. Its highest net income in these years was $49.27M, in fiscal 2023.
Year by year
| Fiscal year | Gross profit | Operating income | Net income |
|---|---|---|---|
| 2025ended Dec 31, 2025 | $0* | -$153.29M | -$144.74M |
| 2024ended Dec 31, 2024 | $81.42M* | -$314.73M | -$301.74M |
| 2023ended Dec 31, 2023 | $355.35M* | $38.8M | $49.27M |
| 2022ended Dec 31, 2022 | $19.24M* | -$201.34M | -$198.38M |
| 2021ended Dec 31, 2021 | — | -$82.69M | -$87.93M |
Fiscal years as Amylyx Pharmaceuticals, Inc. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on Amylyx Pharmaceuticals, Inc.
- The revenue of Amylyx Pharmaceuticals, Inc.
- The cash flow of Amylyx Pharmaceuticals, Inc.
- The debt of Amylyx Pharmaceuticals, Inc.
- All of Amylyx Pharmaceuticals, Inc.'s financials, charted
Companies of a similar size
- CLBTCellebrite DI Ltd.
- IMAXIMAX Corporation
- KNFKnife River Corporation
- AVAHAveanna Healthcare Holdings Inc.
- EEFTEURONET WORLDWIDE, INC.
Not investment advice. This page shows what Amylyx Pharmaceuticals, Inc. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.